Atlas Trials

Liposomal Doxorubicin-containing Front-line Treatment in Elderly Patients With HL (HL-MVD)

Clinical trial NCT06235047 · COMPLETED

Trial details

NCT number
NCT06235047
Sponsor
Federico II University
Status
COMPLETED
Study type
OBSERVATIONAL
Classic Hodgkin Lymphoma
Start date
2013-01-01
Primary completion
2023-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.